Summary

Gastrointestinal disease is a very common and frequently occurring disease, with a wide range of types and a total incidence of about 20% of the population. The cause of gastrointestinal disease is the imbalance between the protective mechanism and the injury mechanism of the human body. While traditional medicine kills harmful bacteria in the stomach, it also kills the beneficial bacteria necessary for the stomach. Although the symptoms are alleviated and inflammation is eliminated, the reduction of beneficial bacteria reduces the gastrointestinal immunity. Once the drug is stopped, it is easy to re-infect. There are many reasons for stomach problems, including genetics, environment, diet, drugs, bacterial infections, etc., as well as smoking and excessive alcohol consumption. This collection of entries aims to collect various items related to the topic of gastrointestinal diseases, such as clinical care, case cases, disease research, etc., to help people increase their knowledge and understanding of this common disease

Expand All
Entries
Topic Review
Wnt Signaling and Aging of the Gastrointestinal Tract
Wnt signaling plays an essential role in aging of the gastrointestinal tract. Aberration of Wnt signaling seen in aged animals has been shown to affect regenerative capacity and differentiation of intestinal stem cells and promote aging-related deterioration. Similarly, abnormal Wnt signaling was observed in the aged stomach. Specifically, enhanced Wnt signaling in organoids established from the stomachs of aged mice induced the expression of Tbx3, a transcription factor that suppress cellular senescence, and led to augmented cellular proliferation. The enhanced Wnt signaling was due to suppressed Dkk3, a Wnt inhibitor, in aged gastric organoids. With respect to the role of TBX3 in humans, expression of TBX3 in human gastric tissues exhibited positive correlation with patients' age whereas that of DKK3 showed negative correlation with patients' age. In addition, TBX3 expression was also confirmed in gastric cancer tissues but not in normal gastric mucosae. These findings indicated that this DKK3-Wnt-TBX3 pathway may contribute to aging-related gastric carcinogenesis.
  • 425
  • 25 Oct 2022
Topic Review
Gastrointestinal and Liver Complications in Diabetes Mellitus
The number of diabetes mellitus patients has increased in developing countries, along with obesity and sedentary lifestyle. Besides macroangiopathy and microangiopathy, damage to the nerve fibers of the peripheral nervous system is the most common chronic complication of diabetes. Digestive complications in diabetic patients represent a consequence of diabetic autonomic neuropathy involving the gastrointestinal tract, but unfortunately not always evaluated by diabetologists. Aside from the complications encountered in the digestive tract, patients with diabetes mellitus are prone to developing liver diseases.
  • 634
  • 24 Oct 2022
Topic Review
Immune Checkpoint Inhibitor in Gastrointestinal Tumors
Immune checkpoint inhibitors (ICIs) are now incorporated into the management of GI tumors. The heterogenous nature of these tumors, however, reveals a lack of ICI consistency in effectiveness. Certain biomarkers have emerged as being potentially predictive for ICI effectiveness.
  • 357
  • 18 Oct 2022
Topic Review
Host Cell Antimicrobial Responses against Helicobacter pylori Infection
The colonization of Helicobacter pylori (H. pylori) in human gastric mucosa is highly associated with the occurrence of gastritis, peptic ulcer, and gastric cancer. Antibiotics, including amoxicillin, clarithromycin, furazolidone, levofloxacin, metronidazole, and tetracycline, are commonly used and considered the major treatment regimens for H. pylori eradication. Evidence has pointed out that a small portion of H. pylori can invade and replicate in the intracellular compartments of different cell types, causing persistent infection by evading host immune defense and antibiotics. Under this circumstance, host cells have developed numerous antimicrobial responses to fight against invading H. pylori, e.g., induction of antimicrobial peptides, activation of cellular autophagy pathway, and increased oxidative stress.
  • 415
  • 18 Oct 2022
Topic Review
The Gut-Immune-Brain Axis in Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic inflammatory disease comprising two major clinical entities—Crohn’s disease (CD) and ulcerative colitis (UC). IBD incidence remains constantly high in industrialized countries and continuously rises in emerging economies. Importantly, IBD is associated with neuropsychiatric symptoms that strongly worsen IBD disease burden. Mounting evidence indicates that chronic gut inflammation induces a systemic immune response that might cause the CNS manifestation in IBD. In line with this, biologicals targeting inflammatory circuits exerted robust positive effects on depressive symptoms in many autoimmune diseases, and in IBD in particular. Therefore, research in recent years increasingly focused on the characterization of local and systemic immune reactions in IBD, and on entry routes of inflammatory cells and molecules into the CNS. The ultimate aim is to understand how the changes in the neuroimmune landscape impair the function of neurons to cause neuropsychiatric symptoms. In addition, the role of intestinal microbiota in the gut–immune–brain axis in IBD will be discussed. 
  • 623
  • 18 Oct 2022
Topic Review
Gut Microbial Modulation
Gut microbial composition codevelops with the host from birth and is influenced by several factors, including drug use, radiation, psychological stress, dietary changes and physical stress. Importantly, gut microbial dysbiosis has been clearly associated with several diseases, including cancer, rheumatoid arthritis and Clostridium difficile-associated diarrhoea, and is known to affect human health and performance.
  • 449
  • 12 Oct 2022
Topic Review
Curcumin Targeting Non-Coding RNAs in Colorectal Cancer
Colorectal cancer is one of the most common gastrointestinal malignancies, with high incidence rates, a low rate of early diagnosis, and complex pathogenesis. In recent years, there has been progress made in its diagnosis and treatment methods, but tumor malignant proliferation and metastasis after treatment still seriously affect the survival and prognosis of patients. Therefore, it is an extremely urgent task of current medicine to find new anti-tumor drugs with high efficiency and safety and low toxicity. Curcumin has shown potent anti-tumor and anti-inflammatory effects and is considered a hot spot in the research and development of anti-tumor drugs due to its advantages of precise efficacy, lower toxic side effects, and less drug resistance. Recent studies have revealed that curcumin has anti-tumor effects exerted on the epigenetic regulation of tumor-promoting/tumor-suppressing gene expression through the alteration of expression levels of non-coding RNAs (e.g., lncRNAs, miRNAs, and circRNAs). The interaction between curcumin and non-coding RNAs on the occurrence and development of colorectal cancer is summarized herein.
  • 548
  • 14 Oct 2022
Topic Review
Immunological Methods of Common Intestinal Protozoa
Intestinal protozoan infection is a persistent public health problem affecting the populations of developing countries in tropical and subtropical regions. The diagnosis of intestinal protozoa remains a challenge especially in developing countries due to a shortage of laboratory facilities, limited health funding, and the remoteness of communities. Despite still being widely used, conventional diagnoses using microscopy and staining methods pose important limitations, particularly due to their low sensitivities and specificities. The selection of diagnostic methods needs to be carefully considered based on the objective of examination, availability of resources, and the expected parasite to be found. Immunodiagnostic tests are generally inexpensive, user-friendly, and enable fast-obtained results. Antibody and antigen detection tests, such as indirect hemagglutination (IHA), indirect immunofluorescence (IIF), enzyme-linked immunosorbent assay (ELISA), direct fluorescent antibody (DFA), rapid enzyme immune assay (EIA), immunochromatographic test (ICT), or latex agglutination, are commercially available via several different platforms. The combination of antibody and fecal antigen detection assays is more sensitive and specific than microscopy for the diagnosis of several intestinal protozoan infections.
  • 615
  • 11 Oct 2022
Topic Review
Gastric Cancer Screening in Japan
Gastric cancer is the second leading cause of cancer incidence in Japan, although gastric cancer mortality has decreased over the past few decades. This decrease is attributed to a decline in the prevalence of H. pylori infection. Radiographic examination has long been performed as the only method of gastric screening with evidence of reduction in mortality in the past. The revised 2014 Japanese Guidelines for Gastric Cancer Screening approved gastric endoscopy for use in population-based screening, together with radiography. While endoscopic gastric cancer screening has begun, there are some problems associated with its implementation, including endoscopic capacity, equal access, and cost-effectiveness. As H. pylori infection and atrophic gastritis are well-known risk factors for gastric cancer, a different screening method might be considered, depending on its association with the individual’s background and gastric cancer risk.
  • 778
  • 08 Oct 2022
Topic Review
Polyploidy and Ploidy Alterations in Hepatocytes
Polyploidy, a condition in which more than two sets of chromosomes are present in a cell, is a characteristic feature of hepatocytes. A significant number of hepatocytes physiologically undergo polyploidization at a young age. Polyploidization of hepatocytes is enhanced with age and in a diseased liver. It is worth noting that polyploid hepatocytes can proliferate, in marked contrast to other types of polyploid cells, such as megakaryocytes and cardiac myocytes. Polyploid hepatocytes divide to maintain normal liver homeostasis and play a role in the regeneration of the damaged liver. Furthermore, polyploid hepatocytes have been shown to dynamically reduce ploidy during liver regeneration. Although it is still unclear why hepatocytes undergo polyploidization, accumulating evidence has revealed that alterations in the ploidy in hepatocytes are involved in the pathophysiology of liver cirrhosis and carcinogenesis. 
  • 398
  • 28 Sep 2022
  • Page
  • of
  • 39

Featured Entry Collections

>>